Archives
-
Taltirelin Acetate: OSA and Neuroprotection Workflows
2026-08-15
Taltirelin acetate supports distinct preclinical workflows, from sleep-state analysis of hypoglossal motor output to neuroprotection assays and formulation testing. This guide translates the reference study into practical dosing, controls, troubleshooting, and cross-application decision points.
-
O6-Benzylguanine: MGMT Inhibition Workflow
2026-08-14
O6-Benzylguanine enables controlled MGMT blockade for studying DNA repair inhibition and sensitization to alkylating agents. This workflow connects mechanistic enzyme inhibition with recurrent glioma models, combination-dose design, and practical troubleshooting for cancer chemotherapy research.
-
FAST Nanoparticles for Food-Grade Nutraceutical Delivery
2026-08-14
Cai and colleagues evaluated Facilitated Self-Assembling Technology (FAST) as a surfactant-free, food-grade route for producing stable nanoparticles from poorly soluble nutraceuticals. The study links spontaneous assembly with improved colloidal behavior, simulated gastric stability, biocompatibility, and fluorescent visualization of nanoparticle–cell interactions, while also identifying limitations that must be addressed before broad translation.
-
NHS-Biotin in Reliable Labeling Workflows
2026-08-13
NHS-Biotin (SKU A8002) provides a practical, amine-reactive route for labeling antibodies, proteins, and intracellular targets used in viability, proliferation, and cytotoxicity workflows. This scenario-based guide explains compatibility, protocol controls, data interpretation, and vendor-selection criteria for more reproducible streptavidin-based detection and purification.
-
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-08-13
Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to extracellular labeling, streptavidin-based capture, and detection workflows, but not to reversible or intracellular biotinylation.
-
A40926 Assay Design: Reliable Antibacterial Data
2026-08-12
Learn how A40926 (SKU BA1486) can support mechanism-led antibacterial assay design, concentration selection, MIC interpretation, and vendor evaluation. This scenario-based guide separates evidence-backed product specifications from workflow recommendations and clarifies the limits of applying antibacterial data to mammalian viability assays.
-
Sulfo-NHS-SS-Biotin: Reversible Surface Labeling
2026-08-12
Sulfo-NHS-SS-Biotin is a water-soluble reagent for primary-amine biotinylation, with a disulfide spacer that enables reversible label removal. The K1006 kit supports protein, antibody, and cell-surface workflows while helping distinguish direct amine labeling from indirect studies of glycoRNA-associated surface domains.
-
SIRT1 Controls Mitochondrial Biogenesis in Prion Models
2026-08-11
Zhao and colleagues show that prion peptide toxicity in N2a cells is associated with reduced SIRT1 abundance and activity, impaired mitochondrial biogenesis, mitochondrial dysfunction, and apoptosis. Their experiments identify a SIRT1–PGC-1α–TFAM pathway and position Resveratrol as a pharmacological probe for restoring mitochondrial homeostasis in this cellular prion model.
-
Tyrothricin in Antimicrobial Research Workflows
2026-08-11
Tyrothricin is a membrane-active peptide antibiotic mixture suited to dose–response, time-kill, and cross-organism antimicrobial studies. This guide translates its composition and storage requirements into reproducible bacterial, fungal, viral, and host-cell assay workflows while keeping mechanistic interpretation appropriately cautious.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-08-10
Qian and colleagues show that Lactobacillus gasseri ATCC33323 protects against DSS-induced colitis in mice by preserving epithelial barrier function through an NR1I3–CDH1/E-cadherin pathway. The study combines probiotic intervention, intestinal E-cadherin perturbation, barrier and inflammatory readouts, microbiota analysis, and in vitro transcriptional experiments to move beyond an association between probiotics and colitis protection.
-
Sulfo-NHS-SS-Biotin for HBV Entry Assays
2026-08-09
Sulfo-NHS-SS-Biotin enables reversible surface-protein measurements that can clarify how NTCP trafficking and CDC42-dependent uptake shape HBV entry. This guide translates recent mechanistic findings into assay design, controls, and interpretation strategies.
-
Sulfo-NHS-SS-Biotin for Reversible Surface Mapping
2026-08-08
Sulfo-NHS-SS-Biotin combines water-compatible amine labeling with a reducible disulfide spacer, enabling both robust capture and controlled release. It is especially useful for cell surface protein labeling, reversible interactome workflows, and protein or antibody purification where permanent biotin can complicate downstream analysis.
-
Lopinavir: From HIV Potency to Assay Insight
2026-08-07
Lopinavir (ABT-378) is a powerful HIV protease inhibitor whose value extends beyond potency measurements. This article explains how to interpret its resistance profile, serum behavior, formulation requirements, and cross-viral cell-culture evidence without confusing phenotypic activity with a proven mechanism.
-
Firefly Luciferase mRNA (5-moUTP): Optimizing Reporter Assay
2026-08-07
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) redefines bioluminescent reporter workflows with robust, high-yield expression and minimized innate immune activation. Its advanced capping and 5-moUTP modifications enable superior stability and translation efficiency, making it a benchmark for mRNA delivery and functional genomics studies.
-
O-GlcNAcylation Drives Wnt-Induced Glycolysis in Bone Format
2026-08-06
This study uncovers how Wnt signaling stimulates bone formation by activating O-GlcNAcylation, which in turn rewires aerobic glycolysis in osteoblasts. The findings highlight a pivotal metabolic mechanism linking Wnt pathway activity to bone anabolism and suggest new molecular targets for osteoporosis therapies.
554 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page